JP2021524245A5 - - Google Patents
Info
- Publication number
- JP2021524245A5 JP2021524245A5 JP2020564923A JP2020564923A JP2021524245A5 JP 2021524245 A5 JP2021524245 A5 JP 2021524245A5 JP 2020564923 A JP2020564923 A JP 2020564923A JP 2020564923 A JP2020564923 A JP 2020564923A JP 2021524245 A5 JP2021524245 A5 JP 2021524245A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- premir
- rna
- polynucleotide according
- premirna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862674939P | 2018-05-22 | 2018-05-22 | |
| US62/674,939 | 2018-05-22 | ||
| PCT/US2019/033232 WO2019226603A1 (en) | 2018-05-22 | 2019-05-21 | Trna/pre-mirna compositions and use in treating cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021524245A JP2021524245A (ja) | 2021-09-13 |
| JP2021524245A5 true JP2021524245A5 (cg-RX-API-DMAC7.html) | 2022-05-23 |
| JP7545726B2 JP7545726B2 (ja) | 2024-09-05 |
Family
ID=68616101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564923A Active JP7545726B2 (ja) | 2018-05-22 | 2019-05-21 | tRNA/プレmiRNA組成物およびがん治療における使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11946049B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3796920A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7545726B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019226603A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019204733A1 (en) * | 2018-04-20 | 2019-10-24 | The Regents Of The University Of California | tRNA/pre-miRNA COMPOSITIONS AND METHODS FOR TREATING HEPATOCELLULAR CARCINOMA |
| GB201919021D0 (en) | 2019-12-20 | 2020-02-05 | Reneuron Ltd | Nucleic acid constructs for delivering polynucleotides into exosomes |
| CN110946872B (zh) * | 2019-12-30 | 2022-11-04 | 北京大学深圳医院 | miR-4491在制备治疗乳腺癌的药物中的应用 |
| BR112022020780A2 (pt) * | 2020-04-14 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Composições de trem e usos das mesmas |
| CN114058697B (zh) * | 2020-07-29 | 2023-08-18 | 四川大学华西医院 | 检测外泌体miR-6774-3p或miR-6776-5p的试剂的用途 |
| WO2022098788A1 (en) * | 2020-11-03 | 2022-05-12 | The Regents Of The University Of California | Bioengineered wnt5a therapeutics for advanced cancers |
| US20230416758A1 (en) * | 2020-11-23 | 2023-12-28 | Thomas Jefferson University | Trna fragments and methods of use |
| US20240327830A1 (en) * | 2022-02-28 | 2024-10-03 | Northwestern University | Dise-inducing srna-polyplexes and srna-lipopolyplexes and methods of using the same to treat cancer |
| IL318039A (en) * | 2022-07-10 | 2025-02-01 | Precigen Inc | Polycistronic microRNA constructs for immune checkpoint inhibition |
| CN115323057A (zh) * | 2022-09-01 | 2022-11-11 | 浙江医院 | 肺癌治疗疗效相关的生物标志物 |
| CN115896295A (zh) * | 2022-12-30 | 2023-04-04 | 中国科学技术大学 | 辅助诊断胆囊炎或预测胆囊炎合并肝损伤的miRNA标志物 |
| CN117126938A (zh) * | 2023-10-08 | 2023-11-28 | 常州市第一人民医院 | 一种用于诊断膜性肾病的生物标志物及其应用方法 |
| WO2025155837A1 (en) * | 2024-01-19 | 2025-07-24 | Massachusetts Institute Of Technology | Modular microrna expression from self-replicating rna (replicons) |
| CN121406635A (zh) * | 2024-05-08 | 2026-01-27 | 西安艾领克生物科技有限公司 | 一种利用活性tRNA在大肠杆菌中嵌合表达重组小RNA的方法及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2728782T3 (es) * | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| US9340799B2 (en) * | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| JP7026440B2 (ja) * | 2014-05-28 | 2022-02-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ハイブリッドtRNA/プレmiRNA分子および使用方法 |
| WO2016153880A2 (en) | 2015-03-23 | 2016-09-29 | The Regents Of The University Of California | Methods for detection of rnase activity |
| WO2019204733A1 (en) | 2018-04-20 | 2019-10-24 | The Regents Of The University Of California | tRNA/pre-miRNA COMPOSITIONS AND METHODS FOR TREATING HEPATOCELLULAR CARCINOMA |
-
2019
- 2019-05-21 JP JP2020564923A patent/JP7545726B2/ja active Active
- 2019-05-21 US US17/056,203 patent/US11946049B2/en active Active
- 2019-05-21 EP EP19806974.2A patent/EP3796920A4/en active Pending
- 2019-05-21 WO PCT/US2019/033232 patent/WO2019226603A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abba et al. | MicroRNAs as novel targets and tools in cancer therapy | |
| Hosseinahli et al. | Treating cancer with microRNA replacement therapy: A literature review | |
| JP7026440B2 (ja) | ハイブリッドtRNA/プレmiRNA分子および使用方法 | |
| Sell et al. | MicroRNAs in cancer metastasis: biological and therapeutic implications | |
| Ivkovic et al. | microRNAs as cancer therapeutics: A step closer to clinical application | |
| Paladini et al. | Targeting microRNAs as key modulators of tumor immune response | |
| Ling et al. | MicroRNAs and other non-coding RNAs as targets for anticancer drug development | |
| Li et al. | MicroRNAs and drug resistance in prostate cancers | |
| Oom et al. | MicroRNAs: novel players in cancer diagnosis and therapies | |
| US20220033815A1 (en) | Systemic in vivo delivery of oligonucleotides | |
| Ishida et al. | miRNA-based therapeutic strategies | |
| JP7545726B2 (ja) | tRNA/プレmiRNA組成物およびがん治療における使用 | |
| McDermott et al. | The therapeutic potential of microRNAs: disease modulators and drug targets | |
| Iorio et al. | Breast cancer and microRNAs: therapeutic impact | |
| Sempere et al. | Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer | |
| Xue et al. | MicroRNA-targeted therapeutics for lung cancer treatment | |
| Braicu et al. | MicroRNAs and cancer therapy–from bystanders to major players | |
| Li et al. | MiRNA-based therapeutic strategy in lung cancer | |
| Ciccone et al. | The small RNA landscape in NSCLC: current therapeutic applications and progresses | |
| Tan et al. | Potential microRNA targets for cancer chemotherapy | |
| Biswas et al. | miRNA-based therapeutic strategies | |
| Abubakar et al. | Exploring Novel Therapeutic Breakthroughs for Cancers: Potential Roles of miRNAs | |
| A Schmid et al. | The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies | |
| Yu et al. | Overcoming drug resistance in colorectal cancer by microRNAs | |
| Aledani et al. | MicroRNAs: New non-invasive diagnostic biomarkers and therapeutic method for cancer treatment: MicroRNAs: New non-invasive diagnostic biomarkers and therapeutic method for cancer treatment |